Rallybio Corporaton (RLYB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6700 -0.0300 (-4.29%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6700 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Cash Flows From Operating Activities | |||||
Net Income | -57,775 | -46,731 | -35,265 | -19,029 | -74,564 |
Depreciation Amortization | -1,481 | -1,195 | -886 | -504 | -2,939 |
Accounts payable and accrued liabilities | -698 | -393 | 242 | -506 | -99 |
Other Working Capital | -258 | 667 | 5,101 | 1,303 | 4,277 |
Other Operating Activity | 10,930 | 8,232 | 4,933 | 3,279 | 13,060 |
Operating Cash Flow | $-49,282 | $-39,420 | $-25,875 | $-15,457 | $-60,265 |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | N/A | N/A | N/A | -12 |
Purchase Of Investment | -50,933 | -33,609 | -31,390 | -11,486 | -110,664 |
Sale Of Investment | 84,425 | 68,674 | 44,250 | 21,750 | 138,334 |
Investing Cash Flow | $33,492 | $35,065 | $12,860 | $10,264 | $27,658 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 5,467 | 5,449 | 5,449 | N/A | 282 |
Other Financing Activity | -268 | -268 | -257 | 0 | -139 |
Financing Cash Flow | $5,199 | $5,181 | $5,192 | $N/A | $143 |
Beginning Cash Position | 24,494 | 24,494 | 24,494 | 24,494 | 56,958 |
End Cash Position | 13,903 | 25,320 | 16,671 | 19,301 | 24,494 |
Net Cash Flow | $-10,591 | $826 | $-7,823 | $-5,193 | $-32,464 |
Free Cash Flow | |||||
Operating Cash Flow | -49,282 | -39,420 | -25,875 | -15,457 | -60,265 |
Capital Expenditure | N/A | N/A | N/A | N/A | -12 |
Free Cash Flow | -49,282 | -39,420 | -25,875 | -15,457 | -60,277 |